n-cyclopropyl adenosine-5'-carboxamide has been researched along with bw 723c86 in 1 studies
Studies (n-cyclopropyl adenosine-5'-carboxamide) | Trials (n-cyclopropyl adenosine-5'-carboxamide) | Recent Studies (post-2010) (n-cyclopropyl adenosine-5'-carboxamide) | Studies (bw 723c86) | Trials (bw 723c86) | Recent Studies (post-2010) (bw 723c86) |
---|---|---|---|---|---|
14 | 0 | 5 | 16 | 0 | 8 |
Protein | Taxonomy | n-cyclopropyl adenosine-5'-carboxamide (IC50) | bw 723c86 (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.2043 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.8738 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.6257 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 2.7743 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 1.1278 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.6257 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.2043 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 1.1278 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 4.785 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0811 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.6414 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 2.6846 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
1 other study(ies) available for n-cyclopropyl adenosine-5'-carboxamide and bw 723c86
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |